170 related articles for article (PubMed ID: 31961260)
1. Barriers to access and utilization of multiple sclerosis care services in a large cohort of Latin American patients.
Carnero Contentti E; Giachello S; Correale J
Mult Scler; 2021 Jan; 27(1):117-129. PubMed ID: 31961260
[TBL] [Abstract][Full Text] [Related]
2. Indirect impact of the COVID-19 pandemic on the care and outcomes of people with MS: A combined survey and insurance claims study.
Meltzer E; Charron O; Wozny J; Onuorah H; Montague A; Kline AC; Largent A; Krause TM; Freeman L
Mult Scler Relat Disord; 2023 Dec; 80():105085. PubMed ID: 37931487
[TBL] [Abstract][Full Text] [Related]
3. Changes on the health care of people with multiple sclerosis from Latin America during the COVID-19 pandemic.
Chertcoff A; Bauer J; Silva BA; Aldecoa M; Eizaguirre MB; Rodriguez R; Chereque A; Rodríguez Heudebert ML; Milanesi V; Morales L; Castellón M; Mejía Pineda S; Ferrandina F; Henestroza P; Ruiz Peraza M; Vallecillo Rivas F; Cedeño Lopez L; Herrera L; Sosa M; Cruchet Muñoz V; Barahona AS; Ramírez Gudiño LM; Carballido S; Walton C; Peeters LM; Rijke N; Garcea O; Carrá A; Alonso R
Mult Scler Relat Disord; 2021 Sep; 54():103120. PubMed ID: 34243104
[TBL] [Abstract][Full Text] [Related]
4. Access and unmet needs to multiple sclerosis care in a cohort of Argentinean patients.
Carnero Contentti E; Pettinicchi JP; López PA; Alonso R; Garcea O; Balbuena ME; Bortoluzzi C; Silva E; Cabrera M; Curbelo MC; Hryb JP; Di Pace JL; Perassolo M; Ianardi S; Mainella C; Mellinger S; Migliacci L; Pagani Cassara F; Sinay V; Carra A; Qüesta Laudani M; Ruiz Romagnoli E; Liwacki S; Piedrabuena R; Tizio S; Tkachuk V
Mult Scler Relat Disord; 2019 Aug; 33():88-93. PubMed ID: 31174044
[TBL] [Abstract][Full Text] [Related]
5. Access and barriers to MS care in Latin America.
Rivera VM; Macias MA
Mult Scler J Exp Transl Clin; 2017; 3(1):2055217317700668. PubMed ID: 28607755
[TBL] [Abstract][Full Text] [Related]
6. Unmet needs, burden of treatment, and patient engagement in multiple sclerosis: A combined perspective from the MS in the 21st Century Steering Group.
; Rieckmann P; Centonze D; Elovaara I; Giovannoni G; Havrdová E; Kesselring J; Kobelt G; Langdon D; Morrow SA; Oreja-Guevara C; Schippling S; Thalheim C; Thompson H; Vermersch P; Aston K; Bauer B; Demory C; Giambastiani MP; Hlavacova J; Nouvet-Gire J; Pepper G; Pontaga M; Rogan E; Rogalski C; van Galen P; Ben-Amor AF
Mult Scler Relat Disord; 2018 Jan; 19():153-160. PubMed ID: 29241142
[TBL] [Abstract][Full Text] [Related]
7. Descriptive analysis of free-text comments on healthcare priorities and experiences in a national sample of people with multiple sclerosis.
Chiu C; Park M; Hoffman T; Campbell M; Bishop M
Mult Scler Relat Disord; 2019 Sep; 34():141-149. PubMed ID: 31277032
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of adherence to treatment in patients with multiple sclerosis from Latin America.
Alonso R; Rojas JI; Ramos J; Correa P; Pita C; Cohen L; Vanotti S; Garcea O; Silva BA
Mult Scler Relat Disord; 2022 Jul; 63():103915. PubMed ID: 35700671
[TBL] [Abstract][Full Text] [Related]
9. Multi-actor system dynamics in access to disease-modifying treatments for multiple sclerosis in Southeast Asia: A regional survey and suggestions for improvement.
Viswanathan S; Vijayasingham L; Laurson-Doube J; Quek AML; Tan K; Yeo T; Seinn MMA; Ohnmar O; Estiasari R; Yassin N; Hiew FL; Pasco PM; Hoang NTT; Keosodsay S; Siritho S; Apiwattanakul M; Ros S; Dias de Deus BS; Remli R; Abdullah S; Lim SY
Mult Scler Relat Disord; 2024 May; 85():105555. PubMed ID: 38547547
[TBL] [Abstract][Full Text] [Related]
10. The Impact of Disease-Modifying Therapy Access Barriers on People With Multiple Sclerosis: Mixed-Methods Study.
Simacek KF; Ko JJ; Moreton D; Varga S; Johnson K; Katic BJ
J Med Internet Res; 2018 Oct; 20(10):e11168. PubMed ID: 30377144
[TBL] [Abstract][Full Text] [Related]
11. A Targeted Literature Search and Phenomenological Review of Perspectives of People with Multiple Sclerosis and Healthcare Professionals of the Immunology of Disease-Modifying Therapies.
Burtchell J; Clemmons D; Clemmons J; Sabutis T; Rosenberg A; Graves J; Sweeney ML; Kramer J; Ziehn M; Brown B; Weiss JL; Obeidat AZ
Neurol Ther; 2022 Sep; 11(3):955-979. PubMed ID: 35608740
[TBL] [Abstract][Full Text] [Related]
12. Research priorities in multiple sclerosis in Latin America: A multi-stakeholder call to action to improve patients care: Research priorities in MS in LATAM.
Rojas JI; Carnero Contentti E; Abad P; Aguayo A; Alonso R; Bauer J; Becker J; Bustos AK; Carcamo CA; Carra A; Correa Diaz EP; Correale J; Cristiano E; Diaz AJ; Fernandez Liguori N; Flores J; Fruns M; Garcea O; Giachello SM; Godoy MD; Gracia F; Hamuy VF; Henestroza PR; Navarra JA; Navas C; Patrucco L; Perez Bruno M; Prato AS; Rivera VM; Rosa Martinez AR; Vanotti S; Vazquez M; Vizcarra D; Ysrraelit MC; Alonso Serena M;
Mult Scler Relat Disord; 2021 Aug; 53():103038. PubMed ID: 34090128
[TBL] [Abstract][Full Text] [Related]
13. Disease-modifying therapy prescription patterns in people with multiple sclerosis by age.
Zhang Y; Salter A; Jin S; Culpepper WJ; Cutter GR; Wallin M; Stuve O
Ther Adv Neurol Disord; 2021; 14():17562864211006499. PubMed ID: 33868459
[TBL] [Abstract][Full Text] [Related]
14. Factors influencing patients' willingness-to-pay for disease-modifying therapies for multiple sclerosis.
Poudel N; Banjara B; Kamau S; Frost N; Ngorsuraches S
Mult Scler Relat Disord; 2021 Feb; 48():102720. PubMed ID: 33429304
[TBL] [Abstract][Full Text] [Related]
15. Multiple Sclerosis Multidisciplinary Care: A National Survey and Lessons for the Global Community.
Van Hijfte L; Cambron M; Capron B; Dachy B; Decoo D; Dive D; Dubois B; Sankari SE; London F; Perrotta G; Popescu V; Van Pesch V; Van Wijmeersch B; Willekens B; Laureys G;
Mult Scler Relat Disord; 2024 May; 85():105540. PubMed ID: 38489948
[TBL] [Abstract][Full Text] [Related]
16. Challenges in multiple sclerosis care: Results from an international mixed-methods study.
Péloquin S; Schmierer K; Leist TP; Oh J; Murray S; Lazure P
Mult Scler Relat Disord; 2021 May; 50():102854. PubMed ID: 33690086
[TBL] [Abstract][Full Text] [Related]
17. The importance of the patient's perspective in decision-making in multiple sclerosis: Results of the OwnMS patient perspectives study.
Florio-Smith J; Ayer M; Colhoun S; Daykin N; Hamill B; Liu X; Rogers E; Thomson A; Balzan RP
Mult Scler Relat Disord; 2023 Jul; 75():104757. PubMed ID: 37210990
[TBL] [Abstract][Full Text] [Related]
18. Impact of the COVID-19 pandemic on the health care of >1,000 People living with multiple sclerosis: A cross-sectional study.
Vogel AC; Schmidt H; Loud S; McBurney R; Mateen FJ
Mult Scler Relat Disord; 2020 Nov; 46():102512. PubMed ID: 32977074
[TBL] [Abstract][Full Text] [Related]
19. How the COVID-19 Pandemic has changed multiple sclerosis clinical practice: Results of a nationwide provider survey.
Morrison EH; Michtich K; Hersh CM
Mult Scler Relat Disord; 2021 Jun; 51():102913. PubMed ID: 33839482
[TBL] [Abstract][Full Text] [Related]
20. An evaluation of the role of community care in meeting the needs of people with multiple sclerosis in Ireland.
Maguire R; Deane-King J; Fahy A; Larkin A; Coote S
Mult Scler Relat Disord; 2023 Jan; 69():104419. PubMed ID: 36413916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
